SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-040188
Filing Date
2023-11-13
Accepted
2023-11-09 20:45:00
Documents
14
Period of Report
2023-11-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53472
2 ex99-1.htm EX-99.1 23326
3 ex99-2.htm EX-99.2 123723
  Complete submission text file 0001493152-23-040188.txt   402961

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT invo-20231109.xsd EX-101.SCH 3033
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT invo-20231109_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT invo-20231109_pre.xml EX-101.PRE 22371
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 2926
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 231394360
SIC: 3841 Surgical & Medical Instruments & Apparatus